Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Vitespen |
Trade Name | |
Synonyms | Oncophage|HSPPC-96 |
Drug Descriptions |
Oncophage (vitespen) is a cancer vaccine that uses gp96 as an antigen, which may induce immune response against tumor cells expressing gp96 (PMID: 11727524). |
DrugClasses | |
CAS Registry Number | 492448-75-6 |
NCIT ID | C2432 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + Temozolomide + Vitespen | Pembrolizumab Temozolomide Vitespen | 0 | 1 |
Vitespen | Vitespen | 0 | 1 |